A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors

NCT05141240 · clinicaltrials.gov ↗

COMPLETED

Status

4650

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Ribiciclib
DRUG: Palbociclib
DRUG: Abemaciclib

Sponsor

Novartis Pharmaceuticals